- Home
- AXGN vs REFI Comparison
AXGN vs REFI Comparison
Compare AXGN & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- REFI
- Stock Information
- Founded
- AXGN N/A
- REFI 2021
- Country
- AXGN United States
- REFI United States
- Employees
- AXGN N/A
- REFI N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- REFI Real Estate Investment Trusts
- Sector
- AXGN Health Care
- REFI Real Estate
- Exchange
- AXGN Nasdaq
- REFI Nasdaq
- Market Cap
- AXGN 584.7M
- REFI 306.1M
- IPO Year
- AXGN N/A
- REFI 2021
- Fundamental
- Price
- AXGN $13.15
- REFI $15.46
- Analyst Decision
- AXGN Strong Buy
- REFI Buy
- Analyst Count
- AXGN 4
- REFI 2
- Target Price
- AXGN $15.00
- REFI $20.00
- AVG Volume (30 Days)
- AXGN 370.0K
- REFI 74.9K
- Earning Date
- AXGN 11-05-2024
- REFI 11-07-2024
- Dividend Yield
- AXGN N/A
- REFI 12.16%
- EPS Growth
- AXGN N/A
- REFI N/A
- EPS
- AXGN N/A
- REFI 1.97
- Revenue
- AXGN $173,482,000.00
- REFI $55,186,946.00
- Revenue This Year
- AXGN $18.49
- REFI N/A
- Revenue Next Year
- AXGN $12.78
- REFI $4.51
- P/E Ratio
- AXGN N/A
- REFI $7.85
- Revenue Growth
- AXGN 17.26
- REFI 5.63
- 52 Week Low
- AXGN $3.45
- REFI $13.86
- 52 Week High
- AXGN $15.23
- REFI $17.65
- Technical
- Relative Strength Index (RSI)
- AXGN 44.12
- REFI 43.84
- Support Level
- AXGN $13.08
- REFI $15.37
- Resistance Level
- AXGN $15.23
- REFI $15.85
- Average True Range (ATR)
- AXGN 0.65
- REFI 0.14
- MACD
- AXGN -0.17
- REFI 0.01
- Stochastic Oscillator
- AXGN 12.97
- REFI 32.76
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.